ODC vs ACCO vs RCUS vs SPB vs CENT

For growth investors, Oil-Dri Corporation of America (ODC) is the stronger pick with 11.

0% revenue growth year-over-year, versus -8. 5% for ACCO Brands Corporation (ACCO). ACCO Brands Corporation (ACCO) offers the better valuation at 9. 2x trailing P/E (4. 8x forward), making it the more compelling value choice. Analysts rate Arcus Biosciences, Inc. (RCUS) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, ACCO Brands Corporation (ACCO) is the cheapest at 9.

2x versus Spectrum Brands Holdings, Inc. at 20. 4x. On forward P/E, ACCO Brands Corporation is actually cheaper at 4. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Oil-Dri Corporation of America wins at 0. 93x versus Central Garden & Pet Company's 4. 52x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Oil-Dri Corporation of America (ODC) delivered a total return of +345.

3%, compared to -39. 3% for ACCO Brands Corporation (ACCO). Over 10 years, the gap is even starker: ODC returned +386. 5% versus ACCO's -35. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Oil-Dri Corporation of America (ODC) is the lower-risk stock at 0.

34β versus Arcus Biosciences, Inc. 's 1. 95β — meaning RCUS is approximately 480% more volatile than ODC relative to the S&P 500. On balance sheet safety, Arcus Biosciences, Inc. (RCUS) carries a lower debt/equity ratio of 16% versus 139% for ACCO Brands Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Oil-Dri Corporation of America (ODC) is pulling ahead at 11.

0% versus -8. 5% for ACCO Brands Corporation (ACCO). On earnings-per-share growth, the picture is similar: ACCO Brands Corporation grew EPS 141. 5% year-over-year, compared to -5. 6% for Spectrum Brands Holdings, Inc.. Over a 3-year CAGR, RCUS leads at 30. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Oil-Dri Corporation of America (ODC) is the more profitable company, earning 10.

6% net margin versus -142. 9% for Arcus Biosciences, Inc. — meaning it keeps 10. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ODC leads at 14. 0% versus -156. 3% for RCUS. At the gross margin level — before operating expenses — RCUS leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Oil-Dri Corporation of America (ODC) is the more undervalued stock at a PEG of 0. 93x versus Central Garden & Pet Company's 4. 52x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ACCO Brands Corporation (ACCO) trades at 4. 8x forward P/E versus 21. 5x for Oil-Dri Corporation of America — 16. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACCO: 97. 0% to $8. 00.

In this comparison, ACCO (7.

1% yield), SPB (2. 4% yield), ODC (0. 7% yield) pay a dividend. RCUS, CENT do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Oil-Dri Corporation of America (ODC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

34), 0. 7% yield, +386. 5% 10Y return). Arcus Biosciences, Inc. (RCUS) carries a higher beta of 1. 95 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ODC: +386. 5%, RCUS: +45. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ODC (Basic Materials) and ACCO (Industrials) and RCUS (Healthcare) and SPB (Consumer Defensive) and CENT (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ODC is a small-cap quality compounder stock; ACCO is a small-cap deep-value stock; RCUS is a small-cap quality compounder stock; SPB is a small-cap quality compounder stock; CENT is a small-cap deep-value stock. ODC, ACCO, SPB pay a dividend while RCUS, CENT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.